efavirenz and Coronary Disease

efavirenz has been researched along with Coronary Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cohn, S; Currier, J; Koletar, S; McCutchan, J; Murphy, R; Williams, P; Wu, J	1
Massari, V; Parienti, JJ; Poubeau, P; Rey, D; Verdon, R	1

Trials

2 trial(s) available for efavirenz and Coronary Disease

Article	Year
Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution. HIV medicine, 2009, Volume: 10, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Body Fat Distribution; Cardiovascular Diseases; Coronary Disease; Cyclopropanes; Drug Therapy, Combination; Epidemiologic Methods; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Immune Reconstitution Inflammatory Syndrome; Male; Metabolic Syndrome; Middle Aged; Treatment Outcome	2009
Efavirenz to nevirapine switch in HIV-1-infected patients with dyslipidemia: a randomized, controlled study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jul-15, Volume: 45, Issue:2 Topics: Alkynes; Benzoxazines; Cholesterol, LDL; Coronary Disease; Cross-Over Studies; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyslipidemias; Female; Follow-Up Studies; HIV Infections; Humans; Male; Nevirapine; Reverse Transcriptase Inhibitors; Severity of Illness Index; Single-Blind Method; Treatment Outcome	2007

Article

Year

Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution.

HIV medicine, 2009, Volume: 10, Issue:5

Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Body Fat Distribution; Cardiovascular Diseases; Coronary Disease; Cyclopropanes; Drug Therapy, Combination; Epidemiologic Methods; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Immune Reconstitution Inflammatory Syndrome; Male; Metabolic Syndrome; Middle Aged; Treatment Outcome

2009

Efavirenz to nevirapine switch in HIV-1-infected patients with dyslipidemia: a randomized, controlled study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jul-15, Volume: 45, Issue:2

Topics: Alkynes; Benzoxazines; Cholesterol, LDL; Coronary Disease; Cross-Over Studies; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyslipidemias; Female; Follow-Up Studies; HIV Infections; Humans; Male; Nevirapine; Reverse Transcriptase Inhibitors; Severity of Illness Index; Single-Blind Method; Treatment Outcome

2007